The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2023

Filed:

Mar. 29, 2019
Applicant:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;

Inventors:

Yinsheng Zhang, Lianyungang, CN;

Wangwei Ao, Lianyungang, CN;

Yuan Li, Lianyungang, CN;

Hui Wang, Lianyungang, CN;

Hangzhou Shen, Lianyungang, CN;

Jie Ni, Lianyungang, CN;

Huan Zhang, Lianyungang, CN;

Jie Wu, Lianyungang, CN;

Li Zhang, Lianyungang, CN;

Kai Cao, Lianyungang, CN;

Peng Lu, Lianyungang, CN;

Xushi Liu, Lianyungang, CN;

Jie Wang, Lianyungang, CN;

Tianxiao Zhao, Lianyungang, CN;

Xingfeng Ge, Lianyungang, CN;

Dandan Lu, Lianyungang, CN;

Shuo Chen, Lianyungang, CN;

Xueqin Ma, Lianyungang, CN;

Wei Shi, Lianyungang, CN;

Xiaojin Wang, Lianyungang, CN;

Hongjiang Xu, Lianyungang, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 207/34 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07D 207/34 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01);
Abstract

A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.


Find Patent Forward Citations

Loading…